Card-20(22)-enolide,3-[(O-b-D-glucopyranosyl-(1®4)-O-3-O-acetyl-2,6-dideoxy-b-D-ribo-hexopyranosyl-(1®4)-O-2,6-dideoxy-b-D-ribo-hexopyranosyl-(1®4)-2,6-dideoxy-b-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-,(3b,5b,12b)- cas no:17575-22-3

NameCard-20(22)-enolide,3-[(O-b-D-glucopyranosyl-(1®4)-O-3-O-acetyl-2,6-dideoxy-b-D-ribo-hexopyranosyl-(1®4)-O-2,6-dideoxy-b-D-ribo-hexopyranosyl-(1®4)-2,6-dideoxy-b-D-ribo-hexopyranosyl)oxy]-12,14-dihydroxy-,(3b,5b,12b)-
CAS17575-22-3
SynonymsLanatosideC (8CI); Allocor; Cedilanid; Ceglunat; Ceglunate; Celadigal; Celanid; Celanide;Cetosanol; Digilanide C; Digilanogen C; Isolanid; Isolanide; Lanatigen C;Lanimerck; NSC 119991; NSC 7533
EINECS(EC#)241-546-1
Molecular FormulaC49H76 O20
Molecular Weight985.25

refractive index1.608
storage temp−20°C

Hazard T: Toxic;
Risk 23/24/25
Safety

Safety Information of Lanatoside C (CAS NO. 17575-22-3):
Hazard Codes: T 
Risk Statements: 23/24/25
R23/24/25:Toxic by inhalation, in contact with skin and if swallowed
Safety Statements: 36/37/39-45
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
RIDADR: UN 2811 6.1/PG 2
WGK Germany: 3
RTECS: OE2100000
Poison by ingestion, intraperitoneal, and intravenous routes. When heated to decomposition it emits acrid smoke and irritating fumes.

1.		ipr-rat LDLo:10 mg/kg		TXAPA9    Toxicology and Applied Pharmacology. 1 (1959),156.
2.		ivn-rat LD50:30 mg/kg		AIPTAK    Archives Internationales de Pharmacodynamie et de Therapie. 155 (1965),165.
3.		ipr-mus LD50:7 mg/kg		AIPTAK    Archives Internationales de Pharmacodynamie et de Therapie. 155 (1965),165.
4.		ivn-mus LD50:8100 µg/kg		NIIRDN    “Drugs in Japan. Ethical Drugs, 6th Edition 1982“ Edited by Japan Pharmaceutical Information Center. 6 (1982),877.
5.		ivn-dog LD50:340 µg/kg		IVEJAC    Indian Veterinary Journal. 57 (1980),31.
6.		ivn-cat LDLo:230 µg/kg		ARZNAD    Arzneimittel-Forschung. Drug Research. 19 (1969),657.
7.		orl-gpg LD50:100 mg/kg		ARZNAD    Arzneimittel-Forschung. Drug Research. 15 (1965),481.
8.		ivn-gpg LDLo:502 µg/kg		ARZNAD    Arzneimittel-Forschung. Drug Research. 17 (1967),1237.